US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 2.2500
  • +0.0500+2.27%
Close Jan 22 16:00 ET
  • 2.2200
  • -0.0300-1.33%
Post 20:01 ET
81.22MMarket Cap-0.51P/E (TTM)

Inovio Pharmaceuticals Key Stats

Inovio Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 100.000K--
--2024/Q4-- / 25.000K--
Nov 14, 20242024/Q30.000 / 104.500K--
Aug 8, 20242024/Q2100.760K / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 100.000K--
--2024/Q4-- / 25.000K--
Nov 14, 20242024/Q30.000 / 104.500K--
Aug 8, 20242024/Q2100.760K / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--

Unlock Free Earnings Estimates

Inovio Pharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 13, 2025

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data